Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Comparison between combination chemotherapy and total body irradiation plus combination chemotherapy in non-Hodgkin's lymphoma. [Effectiveness and complications]

Journal Article · · Cancer; (United States)
OSTI ID:6000529

Thirty-nine untreated patients with either lymphocytic or nodular mixed/nodular histiocytic non-Hodgkin's lymphoma, stage II-IV, were randomized to treatment with total body irradiation (TBI), 100 rads in 10 fractions over 12 days, plus combination chemotherapy with either cyclophosphamide, vincristine and prednisone (CVP) or cyclophosphamide, vincristine, procarbazine and prednisone (C-MOPP) or to treatment with combination chemotherapy (CVP or C-MOPP) alone. Remission rate and duration were comparable for both treatment groups; thus the use of both treatment modalities ab initio provides no therapeutic advantage.

Research Organization:
National Cancer Inst., Bethesda, MD
OSTI ID:
6000529
Journal Information:
Cancer; (United States), Journal Name: Cancer; (United States) Vol. 43:6; ISSN CANCA
Country of Publication:
United States
Language:
English

Similar Records

Combination chemotherapy of lymphomas other than Hodgkin's disease. [Vincristine, prednisone, cyclophosphamide, procarbazine]
Journal Article · Thu Oct 31 23:00:00 EST 1974 · Ann. Intern. Med.; (United States) · OSTI ID:5276418

Total body irradiation and cyclophosphamide, vincristine, prednisone in the treatment of favorable prognosis non-Hodgkin's lymphomas
Conference · Sat Sep 01 00:00:00 EDT 1979 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:5236784

Total body irradiation in non-Hodgkin's lymphoma. [Efficacy and complications]
Journal Article · Wed Jan 31 23:00:00 EST 1979 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:5408200